Covered recipient · General Payments record
HIRA B SIKTEL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$599.87
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $131.36 | 5 |
| Education | $72.23 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Retrophin, Inc. | $135.57 | 11 |
| Lilly USA, LLC | $29.91 | 2 |
| Novo Nordisk AS | $21.80 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Lilly USA, LLC | $15.75 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134982002 | CMS |
| Lilly USA, LLC | $14.16 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135003737 | CMS |
| Novartis Pharmaceuticals Corporation | $16.31 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087158797 | CMS |
| Novo Nordisk Inc | $21.80 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096923402 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 07/30/2024 | Education | Undisputed | 01/23/2026 | 1149900499 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 07/30/2024 | Education | Undisputed | 01/23/2026 | 1149900503 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 07/30/2024 | Education | Undisputed | 01/23/2026 | 1149900507 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 08/05/2024 | Education | Undisputed | 01/23/2026 | 1149900511 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 08/05/2024 | Education | Undisputed | 01/23/2026 | 1149900515 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 08/05/2024 | Education | Undisputed | 01/23/2026 | 1149900519 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 08/05/2024 | Education | Undisputed | 01/23/2026 | 1149900523 | CMS |
| Travere Therapeutics, Inc. | $16.89 | 08/05/2024 | Education | Undisputed | 01/23/2026 | 1149900527 | CMS |
| Travere Therapeutics, Inc. | $16.89 | 08/05/2024 | Education | Undisputed | 01/23/2026 | 1149900531 | CMS |
| Travere Therapeutics, Inc. | $16.89 | 08/05/2024 | Education | Undisputed | 01/23/2026 | 1149900535 | CMS |
| Travere Therapeutics, Inc. | $63.34 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149900539 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.